What happened
L&C BIO filed provisional (unaudited) consolidated results for Q1 2026: revenue of US$20.5M (+70.61% year on year), operating profit of US$4.07M (from a loss a year earlier) and net income of US$1.85M (from a loss a year earlier).
These are preliminary figures the company disclosed ahead of its audited report; the final numbers can differ.
| Revenue | US$20.5M |
|---|---|
| Revenue vs a year earlier | +70.61% |
| Operating profit | US$4.07M |
| Net income | US$1.85M |
| Period | Q1 2026 (consolidated) |
| Filed | 2026-05-11, Operating results (consolidated) (preliminary) (fair disclosure) |
| Source | DART rcept 20260511900300 → open original filing |
Source: DART. Information only, not investment advice.